NCT04021888

Brief Summary

The primary aim of this trial is to investigate the feasibility of an exercise program consisting of respiratory exercises, aerobic exercises and strengthening exercises in mild to moderate Alzheimer's disease. The trial also aims to investigate the effectiveness of the exercise program on respiratory symptoms, exercise capacity, cognition, physical performance, depression, sleepiness, activities of daily living and quality of life. Patients will be divided into exercise (intervention) and control group by randomization method. The study is planned to be performed with a total of 60 patients, 30 in each group. The patients in the exercise group will be given breathing exercises aerobic exercises and strengthening exercises for 2 days a week for 12 weeks, about 30-40 minutes while the patients in the control group will be provided with suggestions, home exercise program and daily life activities

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 16, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2020

Completed
Last Updated

July 17, 2019

Status Verified

July 1, 2019

Enrollment Period

3 months

First QC Date

July 13, 2019

Last Update Submit

July 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in cognition

    The Mini-Mental State Examination (MMSE) is used to measure cognitive impairment in older adults. It assesses different subset of cognitive status including attention, language, memory, orientation, visuospatial proficiency.

    Baseline, 12th week

Secondary Outcomes (9)

  • Change in pulmonary functions

    Baseline, 12th week

  • Change in respiratory muscle strength

    Baseline, 12th week

  • Change in functional capacity

    Baseline, 12th week

  • Change in physical performance

    Baseline, 12th week

  • Change in sleepiness

    Baseline, 12th week

  • +4 more secondary outcomes

Study Arms (2)

Exercise Group

EXPERIMENTAL
Other: Exercise

Control

ACTIVE COMPARATOR
Other: Exercise

Interventions

Education of patients and their caregivers, deep breathing exercise, aerobic exercise and resistance training with elastic bands

ControlExercise Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • aged over 65 years
  • can walk independent

You may not qualify if:

  • can't see
  • have done any exercise in the last 6 months
  • have a major and uncontrolled orthopedic, neurological or cardiopulmonary problem that restricts functioning
  • having non Alzheimer's disease dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elvan Keleş

İzmi̇r, 35620, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Exercise

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Elvan Keleş, PT, PhD

    İzmir Katip Çelebi Üniversitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
An assessor who was blinded to treatment groups assessed clinical outcomes before the treatment process. The same assessor was also repeated assessments at 13th week (at the end of treatment process)
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

July 13, 2019

First Posted

July 16, 2019

Study Start

July 16, 2018

Primary Completion

October 8, 2018

Study Completion

July 30, 2020

Last Updated

July 17, 2019

Record last verified: 2019-07

Locations